APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tiapride Hydrochloride Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tiapride Hydrochloride Tablets Market Outlook and Growth Opportunities 2026

26 December 2025190 pages

Choose your research edition.

Industry ResearchTiapride Hydrochloride Tablets Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Tiapride Hydrochloride Tablets Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Tiapride Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tiapride Hydrochloride Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Tiapride Hydrochloride Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Tiapride Hydrochloride Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tiapride Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tiapride Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tiapride Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tiapride Hydrochloride Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tiapride Hydrochloride Tablets market include Jiangsu Nhwa Pharmaceutical, Tianjin Pharmaceutical Da Ren Tang Group, Astellas Pharma, Tasly Pharmaceuticals, Sawai Pharmaceutical, Nihon Generic and Grand Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tiapride Hydrochloride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tiapride Hydrochloride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tiapride Hydrochloride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tiapride Hydrochloride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Tiapride Hydrochloride Tablets Segment by Company

Jiangsu Nhwa Pharmaceutical

Tianjin Pharmaceutical Da Ren Tang Group

Astellas Pharma

Tasly Pharmaceuticals

Sawai Pharmaceutical

Nihon Generic

Grand Pharmaceutical

Tiapride Hydrochloride Tablets Segment by Type

100mg

50mg

Tiapride Hydrochloride Tablets Segment by Application

Hospital

Clinic

Others

Tiapride Hydrochloride Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tiapride Hydrochloride Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tiapride Hydrochloride Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tiapride Hydrochloride Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Tiapride Hydrochloride Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tiapride Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tiapride Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tiapride Hydrochloride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tiapride Hydrochloride Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tiapride Hydrochloride Tablets industry.

Chapter 3: Detailed analysis of Tiapride Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tiapride Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tiapride Hydrochloride Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tiapride Hydrochloride Tablets Industry Trends Table 2. Tiapride Hydrochloride Tablets Industry Drivers Table 3. Tiapride Hydrochloride Tablets Industry Opportunities and Challenges Table 4. Tiapride Hydrochloride Tablets Industry Restraints Table 5. Global Tiapride Hydrochloride Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tiapride Hydrochloride Tablets Revenue Share by Company (2021-2026) Table 7. Global Tiapride Hydrochloride Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Tiapride Hydrochloride Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Tiapride Hydrochloride Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Tiapride Hydrochloride Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tiapride Hydrochloride Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Tiapride Hydrochloride Tablets Company, Product Type & Application Table 13. Global Tiapride Hydrochloride Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tiapride Hydrochloride Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg Table 18. Significant Companies of 50mg Table 19. Global Tiapride Hydrochloride Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Tiapride Hydrochloride Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Tiapride Hydrochloride Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Tiapride Hydrochloride Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Tiapride Hydrochloride Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Tiapride Hydrochloride Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Tiapride Hydrochloride Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Tiapride Hydrochloride Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Tiapride Hydrochloride Tablets Sales Value Share by Type (2021-2026) Table 28. Global Tiapride Hydrochloride Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Tiapride Hydrochloride Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Tiapride Hydrochloride Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Tiapride Hydrochloride Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Tiapride Hydrochloride Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Tiapride Hydrochloride Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Tiapride Hydrochloride Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Tiapride Hydrochloride Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Tiapride Hydrochloride Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Tiapride Hydrochloride Tablets Sales Value Share by Application (2021-2026) Table 41. Global Tiapride Hydrochloride Tablets Sales Value Share by Application (2027-2032) Table 42. Global Tiapride Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Tiapride Hydrochloride Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Tiapride Hydrochloride Tablets Sales Market Share by Region (2021-2026) Table 45. Global Tiapride Hydrochloride Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Tiapride Hydrochloride Tablets Sales Market Share by Region (2027-2032) Table 47. Global Tiapride Hydrochloride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Tiapride Hydrochloride Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Tiapride Hydrochloride Tablets Sales Value Share by Region (2021-2026) Table 50. Global Tiapride Hydrochloride Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Tiapride Hydrochloride Tablets Sales Value Share by Region (2027-2032) Table 52. Global Tiapride Hydrochloride Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Tiapride Hydrochloride Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Tiapride Hydrochloride Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Tiapride Hydrochloride Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Tiapride Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Tiapride Hydrochloride Tablets Sales Market Share by Country (2021-2026) Table 58. Global Tiapride Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Tiapride Hydrochloride Tablets Sales Market Share by Country (2027-2032) Table 60. Global Tiapride Hydrochloride Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Tiapride Hydrochloride Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Tiapride Hydrochloride Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Tiapride Hydrochloride Tablets Sales Value Market Share by Country (2027-2032) Table 64. Jiangsu Nhwa Pharmaceutical Company Information Table 65. Jiangsu Nhwa Pharmaceutical Business Overview Table 66. Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio Table 68. Jiangsu Nhwa Pharmaceutical Recent Development Table 69. Tianjin Pharmaceutical Da Ren Tang Group Company Information Table 70. Tianjin Pharmaceutical Da Ren Tang Group Business Overview Table 71. Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Product Portfolio Table 73. Tianjin Pharmaceutical Da Ren Tang Group Recent Development Table 74. Astellas Pharma Company Information Table 75. Astellas Pharma Business Overview Table 76. Astellas Pharma Tiapride Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Astellas Pharma Tiapride Hydrochloride Tablets Product Portfolio Table 78. Astellas Pharma Recent Development Table 79. Tasly Pharmaceuticals Company Information Table 80. Tasly Pharmaceuticals Business Overview Table 81. Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Product Portfolio Table 83. Tasly Pharmaceuticals Recent Development Table 84. Sawai Pharmaceutical Company Information Table 85. Sawai Pharmaceutical Business Overview Table 86. Sawai Pharmaceutical Tiapride Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sawai Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio Table 88. Sawai Pharmaceutical Recent Development Table 89. Nihon Generic Company Information Table 90. Nihon Generic Business Overview Table 91. Nihon Generic Tiapride Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Nihon Generic Tiapride Hydrochloride Tablets Product Portfolio Table 93. Nihon Generic Recent Development Table 94. Grand Pharmaceutical Company Information Table 95. Grand Pharmaceutical Business Overview Table 96. Grand Pharmaceutical Tiapride Hydrochloride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Grand Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio Table 98. Grand Pharmaceutical Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Tiapride Hydrochloride Tablets Distributors List Table 102. Tiapride Hydrochloride Tablets Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Tiapride Hydrochloride Tablets Product Image Figure 2. Global Tiapride Hydrochloride Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tiapride Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tiapride Hydrochloride Tablets Sales (2021-2032) & (K Units) Figure 5. Global Tiapride Hydrochloride Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Tiapride Hydrochloride Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg Image Figure 10. 50mg Image Figure 11. Global Tiapride Hydrochloride Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Tiapride Hydrochloride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Tiapride Hydrochloride Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Tiapride Hydrochloride Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Tiapride Hydrochloride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Tiapride Hydrochloride Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Tiapride Hydrochloride Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Tiapride Hydrochloride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Tiapride Hydrochloride Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Tiapride Hydrochloride Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Tiapride Hydrochloride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Tiapride Hydrochloride Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Tiapride Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Tiapride Hydrochloride Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Tiapride Hydrochloride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Tiapride Hydrochloride Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Tiapride Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Tiapride Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Tiapride Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Tiapride Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Tiapride Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Tiapride Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Tiapride Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Tiapride Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Tiapride Hydrochloride Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Tiapride Hydrochloride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Tiapride Hydrochloride Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Tiapride Hydrochloride Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 50mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Jiangsu Nhwa Pharmaceutical
  • Tianjin Pharmaceutical Da Ren Tang Group
  • Astellas Pharma
  • Tasly Pharmaceuticals
  • Sawai Pharmaceutical
  • Nihon Generic
  • Grand Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tiapride Hydrochloride Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Tiapride Hydrochloride Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Tiapride Hydrochloride Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tiapride Hydrochloride Tablets Market Dynamics
  1. 2.1 Tiapride Hydrochloride Tablets Industry Trends
  2. 2.2 Tiapride Hydrochloride Tablets Industry Drivers
  3. 2.3 Tiapride Hydrochloride Tablets Industry Opportunities and Challenges
  4. 2.4 Tiapride Hydrochloride Tablets Industry Restraints
3 Tiapride Hydrochloride Tablets Market by Company
  1. 3.1 Global Tiapride Hydrochloride Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Tiapride Hydrochloride Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Tiapride Hydrochloride Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Tiapride Hydrochloride Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Tiapride Hydrochloride Tablets Company Ranking (2024-2026)
  6. 3.6 Global Tiapride Hydrochloride Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Tiapride Hydrochloride Tablets Company Product Type and Application
  8. 3.8 Global Tiapride Hydrochloride Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tiapride Hydrochloride Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tiapride Hydrochloride Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tiapride Hydrochloride Tablets Market by Type
  1. 4.1 Tiapride Hydrochloride Tablets Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 50mg
  4. 4.2 Global Tiapride Hydrochloride Tablets Sales Volume by Type
  5. 4.2.1 Global Tiapride Hydrochloride Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tiapride Hydrochloride Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Tiapride Hydrochloride Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Tiapride Hydrochloride Tablets Sales Value by Type
  9. 4.3.1 Global Tiapride Hydrochloride Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tiapride Hydrochloride Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Tiapride Hydrochloride Tablets Sales Value Share by Type (2021-2032)
5 Tiapride Hydrochloride Tablets Market by Application
  1. 5.1 Tiapride Hydrochloride Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Tiapride Hydrochloride Tablets Sales Volume by Application
  6. 5.2.1 Global Tiapride Hydrochloride Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tiapride Hydrochloride Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Tiapride Hydrochloride Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Tiapride Hydrochloride Tablets Sales Value by Application
  10. 5.3.1 Global Tiapride Hydrochloride Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tiapride Hydrochloride Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Tiapride Hydrochloride Tablets Sales Value Share by Application (2021-2032)
6 Tiapride Hydrochloride Tablets Regional Sales and Value Analysis
  1. 6.1 Global Tiapride Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tiapride Hydrochloride Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Tiapride Hydrochloride Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Tiapride Hydrochloride Tablets Sales by Region (2027-2032)
  5. 6.3 Global Tiapride Hydrochloride Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tiapride Hydrochloride Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tiapride Hydrochloride Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tiapride Hydrochloride Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Tiapride Hydrochloride Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tiapride Hydrochloride Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Tiapride Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tiapride Hydrochloride Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Tiapride Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tiapride Hydrochloride Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tiapride Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tiapride Hydrochloride Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Tiapride Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tiapride Hydrochloride Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tiapride Hydrochloride Tablets Sales Value Share by Country, 2025 VS 2032
7 Tiapride Hydrochloride Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Tiapride Hydrochloride Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tiapride Hydrochloride Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tiapride Hydrochloride Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Tiapride Hydrochloride Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Tiapride Hydrochloride Tablets Sales by Country (2027-2032)
  6. 7.4 Global Tiapride Hydrochloride Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tiapride Hydrochloride Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tiapride Hydrochloride Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tiapride Hydrochloride Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tiapride Hydrochloride Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tiapride Hydrochloride Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jiangsu Nhwa Pharmaceutical
  2. 8.1.1 Jiangsu Nhwa Pharmaceutical Company Information
  3. 8.1.2 Jiangsu Nhwa Pharmaceutical Business Overview
  4. 8.1.3 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jiangsu Nhwa Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio
  6. 8.1.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  7. 8.2 Tianjin Pharmaceutical Da Ren Tang Group
  8. 8.2.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
  9. 8.2.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview
  10. 8.2.3 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tianjin Pharmaceutical Da Ren Tang Group Tiapride Hydrochloride Tablets Product Portfolio
  12. 8.2.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
  13. 8.3 Astellas Pharma
  14. 8.3.1 Astellas Pharma Company Information
  15. 8.3.2 Astellas Pharma Business Overview
  16. 8.3.3 Astellas Pharma Tiapride Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Astellas Pharma Tiapride Hydrochloride Tablets Product Portfolio
  18. 8.3.5 Astellas Pharma Recent Developments
  19. 8.4 Tasly Pharmaceuticals
  20. 8.4.1 Tasly Pharmaceuticals Company Information
  21. 8.4.2 Tasly Pharmaceuticals Business Overview
  22. 8.4.3 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tasly Pharmaceuticals Tiapride Hydrochloride Tablets Product Portfolio
  24. 8.4.5 Tasly Pharmaceuticals Recent Developments
  25. 8.5 Sawai Pharmaceutical
  26. 8.5.1 Sawai Pharmaceutical Company Information
  27. 8.5.2 Sawai Pharmaceutical Business Overview
  28. 8.5.3 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sawai Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio
  30. 8.5.5 Sawai Pharmaceutical Recent Developments
  31. 8.6 Nihon Generic
  32. 8.6.1 Nihon Generic Company Information
  33. 8.6.2 Nihon Generic Business Overview
  34. 8.6.3 Nihon Generic Tiapride Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nihon Generic Tiapride Hydrochloride Tablets Product Portfolio
  36. 8.6.5 Nihon Generic Recent Developments
  37. 8.7 Grand Pharmaceutical
  38. 8.7.1 Grand Pharmaceutical Company Information
  39. 8.7.2 Grand Pharmaceutical Business Overview
  40. 8.7.3 Grand Pharmaceutical Tiapride Hydrochloride Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Grand Pharmaceutical Tiapride Hydrochloride Tablets Product Portfolio
  42. 8.7.5 Grand Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tiapride Hydrochloride Tablets Value Chain Analysis
  2. 9.1.1 Tiapride Hydrochloride Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tiapride Hydrochloride Tablets Sales Mode & Process
  6. 9.2 Tiapride Hydrochloride Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tiapride Hydrochloride Tablets Distributors
  9. 9.2.3 Tiapride Hydrochloride Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst